INQFocus writer joins 19 other journalists in cancer reporting fellowship | Inquirer News

INQFocus writer joins 19 other journalists in cancer reporting fellowship

/ 04:24 PM August 31, 2023

INQFocus writer joins 19 other journalists in cancer reporting fellowship

ONLINE poster announcing the 20 journalists who made it to the “Think Pink Journalism Fellowship on Reporting Breast Cancer in the Philippines” PHILIPPINE PRESS INSTITUTE

MANILA, Philippines—A researcher and writer of the INQUIRER.net’s INQFocus channel has been chosen as among 20 participants in the Philippine Press Institute (PPI) and Novartis’ fellowship on breast cancer research and reporting.

Cristina Eloisa Baclig, content researcher and writer for INQFocus, was named as one of the journalists taking part in the “Think Pink Journalism Fellowship on Reporting Breast Cancer in the Philippines” organized by PPI and Novartis.

Article continues after this advertisement

INQFocus is a channel in INQUIRER.net dedicated to research, features, and special reports.

FEATURED STORIES

Aside from Baclig, 11 journalists from the National Capital Region (NCR) or Luzon also got the fellowship:

  • Jimmy Domingo, Licas News
  • Anne Ruth Dela Cruz, BusinessMirror
  • Kimberlie Quitasol, Northern Dispatch
  • Villamor Visaya Jr., Luzonwide News Correspondent
  • Celeste Anna Reynoso Formoso, Palawan News
  • Dexter See, Baguio Herald Express
  • Elmer Recuerdo, Daily Tribune
  • Rhadyz Barcia, Manila Times
  • Madonna Tividad Virola, Philippine Daily Inquirer
  • Winnie Aguilar, IBC-13
  • Ruel B. Mazon, Mindoro Bulletin

Seven fellows are from Mindanao:

Article continues after this advertisement
  • Grace Cantal-Albasin, Rappler
  • Yas D. Ocampo, MindaNews
  • Allan Maestrado Mediante, Mindanao Daily News
  • Lina Sagaral Reyes, BukidnonNews.net
  • Julie S. Alipala, Philippine Daily Inquirer Mindanao Bureau
  • Froilan Gallardo, MindaNews
  • Cristina E. Alivio, SunStar Davao

Mildred Galarpe, of SunStar Cebu, was the lone fellow from Visayas.

Article continues after this advertisement

The journalists were chosen by the organizers based on story proposals they submitted on the breast cancer situation in the Philippines.

Article continues after this advertisement

The roster of fellows was officially announced on August 31 at a roundtable, “Inspiring Conversations on Breast Cancer in the Philippines”, organized by the Swiss Chamber of Commerce of the Philippines in partnership with the Philippine Cancer Society and ICanServe Foundation, and supported by Novartis Healthcare Philippines.

The fellowship is also a collaboration among PPI, Novartis Healthcare Philippines, and ICanServe Foundation.

Article continues after this advertisement

Last June, the three organizations signed a memorandum of agreement (MOA) with Novartis to organize a workshop that aims to help local journalists gain a deeper understanding of breast cancer.

The MOA, as well as the fellowship, is supported by the Pharmaceutical and Healthcare Association of the Philippines (PHAP) and the Alliance and Partnerships for Patient Innovations & Solutions (APPIS).

“Media must go beyond reporting just the statistics and give a human face to their stories,” said Rolando Estabillo, PPI chair, in a previous statement.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

“By keeping people and communities informed, this will also empower breast cancer patients and survivors,” Estabillo said.

TAGS: breast cancer, breast cancer Philippines, ICanServe Foundation, INQFocus, Novartis, Philippine Press Institute

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.